CX ‑5461 potentiates imatinib‑induced apoptosis in K562 cells by stimulating < em > KIF1B < /em > expression

In conclusion, the results suggested that the synergistic interaction between CX-5461 and imatinib may be of potential clinical value for the treatment of tyrosine kinase inhibitor-resistant chronic myeloid leukemia.PMID:38356673 | PMC:PMC10865453 | DOI:10.3892/etm.2024.12395

Source: Experimental and Therapeutic Medicine - February 15, 2024 Category: General Medicine Authors: Chaochao Dai Xiaopei Cui Jie Wang Bo Dong Haiqing Gao Mei Cheng Fan Jiang Source Type: research